Impaired neutrophil activity and increased susceptibility to bacterial infection in mice lacking glucose-6-phosphatase-beta
- PMID: 17318259
- PMCID: PMC1797608
- DOI: 10.1172/JCI30443
Impaired neutrophil activity and increased susceptibility to bacterial infection in mice lacking glucose-6-phosphatase-beta
Abstract
Neutropenia and neutrophil dysfunction are common in many diseases, although their etiology is often unclear. Previous views held that there was a single ER enzyme, glucose-6-phosphatase-alpha (G6Pase-alpha), whose activity--limited to the liver, kidney, and intestine--was solely responsible for the final stages of gluconeogenesis and glycogenolysis, in which glucose-6-phosphate (G6P) is hydrolyzed to glucose for release to the blood. Recently, we characterized a second G6Pase activity, that of G6Pase-beta (also known as G6PC), which is also capable of hydrolyzing G6P to glucose but is ubiquitously expressed and not implicated in interprandial blood glucose homeostasis. We now report that the absence of G6Pase-beta led to neutropenia; defects in neutrophil respiratory burst, chemotaxis, and calcium flux; and increased susceptibility to bacterial infection. Consistent with this, G6Pase-beta-deficient (G6pc3-/-) mice with experimental peritonitis exhibited increased expression of the glucose-regulated proteins upregulated during ER stress in their neutrophils and bone marrow, and the G6pc3-/- neutrophils exhibited an enhanced rate of apoptosis. Our results define a molecular pathway to neutropenia and neutrophil dysfunction of previously unknown etiology, providing a potential model for the treatment of these conditions.
Figures








Similar articles
-
Lack of glucose recycling between endoplasmic reticulum and cytoplasm underlies cellular dysfunction in glucose-6-phosphatase-beta-deficient neutrophils in a congenital neutropenia syndrome.Blood. 2010 Oct 14;116(15):2783-92. doi: 10.1182/blood-2009-12-258491. Epub 2010 May 24. Blood. 2010. PMID: 20498302 Free PMC article.
-
Glucose-6-phosphatase-β, implicated in a congenital neutropenia syndrome, is essential for macrophage energy homeostasis and functionality.Blood. 2012 Apr 26;119(17):4047-55. doi: 10.1182/blood-2011-09-377820. Epub 2012 Jan 12. Blood. 2012. PMID: 22246029 Free PMC article.
-
Type I glycogen storage diseases: disorders of the glucose-6-phosphatase/glucose-6-phosphate transporter complexes.J Inherit Metab Dis. 2015 May;38(3):511-9. doi: 10.1007/s10545-014-9772-x. Epub 2014 Oct 7. J Inherit Metab Dis. 2015. PMID: 25288127 Review.
-
Survival and differentiation defects contribute to neutropenia in glucose-6-phosphatase-β (G6PC3) deficiency in a model of mouse neutrophil granulocyte differentiation.Cell Death Differ. 2013 Aug;20(8):1068-79. doi: 10.1038/cdd.2013.39. Epub 2013 May 17. Cell Death Differ. 2013. PMID: 23686134 Free PMC article.
-
Neutropenia in type Ib glycogen storage disease.Curr Opin Hematol. 2010 Jan;17(1):36-42. doi: 10.1097/MOH.0b013e328331df85. Curr Opin Hematol. 2010. PMID: 19741523 Free PMC article. Review.
Cited by
-
Treating neutropenia and neutrophil dysfunction in glycogen storage disease type Ib with an SGLT2 inhibitor.Blood. 2020 Aug 27;136(9):1033-1043. doi: 10.1182/blood.2019004465. Blood. 2020. PMID: 32294159 Free PMC article.
-
Engraftment, Fate, and Function of HoxB8-Conditional Neutrophil Progenitors in the Unconditioned Murine Host.Front Cell Dev Biol. 2022 Jan 20;10:840894. doi: 10.3389/fcell.2022.840894. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35127689 Free PMC article.
-
Gene therapy and genome editing for type I glycogen storage diseases.Front Mol Med. 2023 Mar 31;3:1167091. doi: 10.3389/fmmed.2023.1167091. eCollection 2023. Front Mol Med. 2023. PMID: 39086673 Free PMC article. Review.
-
Severe congenital neutropenia resulting from G6PC3 deficiency with increased neutrophil CXCR4 expression and myelokathexis.Blood. 2010 Oct 14;116(15):2793-802. doi: 10.1182/blood-2010-01-265942. Epub 2010 Jul 8. Blood. 2010. PMID: 20616219 Free PMC article.
-
SLGT2 Inhibitor Rescues Myelopoiesis in G6PC3 Deficiency.J Clin Immunol. 2022 Nov;42(8):1653-1659. doi: 10.1007/s10875-022-01323-4. Epub 2022 Jul 15. J Clin Immunol. 2022. PMID: 35838821
References
-
- Chou J.Y., Matern D., Mansfield B.C., Chen Y.T. Type I glycogen storage diseases: disorders of the glucose-6-phosphatase complex. Curr. Mol. Med. 2002;2:121–143. - PubMed
-
- Chou, J.Y., and Mansfield, B.C. 2003. Glucose-6-phosphate transporter: the key to glycogen storage disease type Ib. In Membrane transporter diseases. S. Broer and C.A. Wagner, editors. Springer. New York, New York, USA. 191–205.
-
- Beaudet A.L., Anderson D.C., Michels V.V., Arion W.J., Lange A.J. Neutropenia and impaired neutrophil migration in type 1B glycogen storage disease. J. Pediatr. 1980;97:906–910. - PubMed
-
- Gitzelmann R., Bosshard N.U. Defective neutrophil and monocyte functions in glycogen storage disease type 1b: a literature review. Eur. J. Pediatr. 1993;152(Suppl.):S33–S38. - PubMed
-
- Rothbaum R., et al. Shwachman-Diamond syndrome: report from an international conference. J. Pediatr. 2002;141:266–270. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Medical
Molecular Biology Databases